Stock screenerAll disclosures →
EDGAR →
PTGX
Conviction 99HealthcareScan · Thu, Jun 25, 2026Gravestone doji
PTGX$122.74+0.48%
ResistanceSupportVol 14Insider sell2
2
2
Vol MA14 883.16K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price122.74
Change+0.48%
Gap+0.86%
Rel volume2.57×
Avg volume814.61K
Avg $ vol88.76M
SMA 20106.96
SMA 50103.78
SMA 20088.72
Price vs 50+18.27%
Price vs 200+38.35%
MA stackbullish
50/200 cross—
Supertrendup · 109.76
RSI (14)73
MACD hist1.84
MACD cross—
Stoch %K / %D88 / 92
ADX (14)38
+DI / −DI36 / 6
RSI divergence—
MACD divergence—
ATR %+3.80%
ADR %4.51%
52w high122.74
52w low49.70
From 52w high+0.00%
Above 52w low+146.96%
New 52w highYes
SqueezeOff
Bollinger width33.02%
%B0.95
Donchian pos89.50%
Donchian high126.26
Donchian low92.75
AVWAP (52w high)123.49
vs AVWAP high-0.61%
AVWAP (52w low)82.27
vs AVWAP low+49.20%
OBV trendUp
Chaikin MF (20)-0.08
Today vs 20d2.57×
Avg vol (14d)883.16K
Avg vol (20d)814.61K
Avg $ vol (20d)88.76M
Market cap7.89B
RS 3m (vs SPY)+9.42%
RS 6m (vs SPY)+34.22%
RS line new highYes
Trend template8/8
Technical rank91.5
1 week+10.14%
1 month+22.76%
3 months+17.67%
6 months+40.42%
1 year+128.65%
YTD+40.79%
P/E-60.65
P/B12.04
P/S—
P/FCF140.75
EPS-2.05
Div yield—
ROE-19.86%
ROA-18.66%
Debt/Eq0.01
Current17.76
EV/EBITDA-49.15
Gross margin—
Net margin—
Rev growth—
EPS growth-147.29%
Price target117.78
Target upside-4.04%
Analyst ratingBuy
Institutional131.46%
Ent. value7.71B
Revenue8.78M
Net income3.78M
Gross profit—
Free cash flow56.08M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out64.31M
Employees131
ListedThu, Aug 11, 2016
Free float59.71M
Float %93.6%
Short interest7.41M
Days to cover16.8d
Short volume55.9%
Squeeze score75 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast$2.11 · 3 est
Last EPS vs est$0.05 vs −$0.65
Last surprise+107.7% beat
Setup gradeA+
Conviction99 / 100
Pattern quality—
Tech rank91.5 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmGravestone doji
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in PTGX
No recent disclosed trades by Congress in PTGX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PTGX · 4 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Waddill William D. Director · Common Stock · 2026-06-23 | Sell | 9K | $1.1M | 2026-06-23 | 2026-06-25 |
Waddill William D. Director · Stock Option (right to buy) · 2026-06-23 | Exercise | 9K | — | 2026-06-23 | 2026-06-25 |
Waddill William D. Director · Common Stock · 2026-06-23 | Exercise | 9K | $149K | 2026-06-23 | 2026-06-25 |
Waddill William D. Director · Common Stock · 2026-05-29 | Exercise | 9K | $106K | 2026-05-29 | 2026-06-01 |
Waddill William D. Director · Stock Option (right to buy) · 2026-05-29 | Exercise | 9K | $0 | 2026-05-29 | 2026-06-01 |
Waddill William D. Director · Common Stock · 2026-05-29 | Sell | 9K | $897K | 2026-05-29 | 2026-06-01 |
PATEL DINESH V PH D President and CEO · Stock Option (right to buy) · 2026-05-12 | Exercise | 75K | $0 | 2026-05-12 | 2026-05-14 |
PATEL DINESH V PH D President and CEO · Common Stock · 2026-05-12 | Sell | 75K | $7.5M | 2026-05-12 | 2026-05-14 |
PATEL DINESH V PH D President and CEO · Common Stock · 2026-05-12 | Exercise | 75K | $1.6M | 2026-05-12 | 2026-05-14 |
PATEL DINESH V PH D President and CEO · Common Stock · 2026-05-12 | Exercise | 75K | $1.6M | 2026-05-12 | 2026-05-12 |
SEC filings
EDGAR filings in PTGX · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.